Location History:
- Jadavpur, IN (2020)
- Kolkata, IN (2021)
Company Filing History:
Years Active: 2020-2021
Title: Innovations of Barnali Paul
Introduction
Barnali Paul is a prominent inventor based in Kolkata, India. She has made significant contributions to the field of immunology through her innovative research and development of novel compounds. With a total of two patents to her name, her work focuses on inhibiting immune stimulation related to toll-like receptors.
Latest Patents
Barnali Paul's latest patents include "Purine based compounds as toll-like receptor 9 antagonist" and "Blocking toll-like receptor 9 signaling with small molecule antagonist." The first patent provides novel purine-based compounds that inhibit signaling through Toll-like receptor 9 (TLR9), which is crucial in treating autoimmune diseases and inflammation. The second patent relates to small molecule compounds that inhibit signaling by TLR9, which is implicated in autoreactive inflammation in various autoimmune diseases. Both inventions depict methods and compositions that can be utilized in clinical applications, including pharmaceutical agents for treating unwanted immune activity.
Career Highlights
Barnali Paul is associated with the Council of Scientific & Industrial Research, where she has been instrumental in advancing research in her field. Her innovative work has garnered attention and recognition within the scientific community.
Collaborations
Some of her notable coworkers include Arindam Talukdar and Dipyaman Ganguly, who have collaborated with her on various research projects.
Conclusion
Barnali Paul's contributions to immunology through her patents highlight her role as a leading inventor in the field. Her innovative approaches to inhibiting immune responses have the potential to impact the treatment of autoimmune diseases significantly.